CORCEPT THERAPEUTICS INC (CORT)

US2183521028 - Common Stock

51.4  +0.25 (+0.49%)

After market: 52.55 +1.15 (+2.24%)

CORCEPT THERAPEUTICS INC

NASDAQ:CORT (12/20/2024, 8:03:39 PM)

After market: 52.55 +1.15 (+2.24%)

51.4

+0.25 (+0.49%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS SubIndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%46.43%
Sales Q2Q%47.69%
CRS91.75
6 Month71.11%
Overview
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-13 2025-02-13/amc
Ins Owners6.48%
Inst Owners87.03%
Market Cap5.39B
Shares104.78M
PE40.79
Fwd PE28.77
Dividend YieldN/A
Analysts83.64
Short Float %18.39%
Short Ratio17.09
IPO04-15 2004-04-15
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CORT Daily chart

Company Profile

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. The company is headquartered in Redwood City, California and currently employs 352 full-time employees. The company went IPO on 2004-04-15. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Company Info

CORCEPT THERAPEUTICS INC

101 Redwood Shores Parkway

Redwood City CALIFORNIA 94025

P: 16506888803

CEO: Joseph K. Belanoff

Employees: 352

Website: https://www.corcept.com/

CORT News

ChartMill News Image3 days ago - ChartmillInvestors should take note of NASDAQ:CORT, a growth stock that remains attractively priced.

CORCEPT THERAPEUTICS INC (NASDAQ:CORT) stands out as a growth opportunity that won't break the bank.

News Image7 days ago - Corcept Therapeutics IncorporatedCorcept’s Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism
News Image10 days ago - Corcept Therapeutics IncorporatedCorcept Announces Positive Results in Treatment Phase of CATALYST Trial in Patients With Hypercortisolism (Cushing’s Syndrome) and Difficult-to-Control Diabetes
ChartMill News Image11 days ago - ChartmillExploring high growth characteristics of CORCEPT THERAPEUTICS INC (NASDAQ:CORT).

Exploring high growth characteristics of CORCEPT THERAPEUTICS INC (NASDAQ:CORT).

ChartMill News Image11 days ago - ChartmillNASDAQ:CORT, a strong growth stock, setting up for a breakout.

CORCEPT THERAPEUTICS INC (NASDAQ:CORT) qualifies as a high growth stock and is consolidating.

News Image11 days ago - Corcept Therapeutics IncorporatedCorcept Announces Results From Phase 2 Study of Dazucorilant in Patients With Amyotrophic Lateral Sclerosis (ALS)

CORT Twits

Here you can normally see the latest stock twits on CORT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example